NOXOPHARM LTD has a total of 31 patent applications. It decreased the IP activity by 95.0%. Its first patent ever was published in 2016. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are PLX PHARMA INC, PAINREFORM LTD and KOMIPHARM INT AUSTRALIA PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Canada | 5 | |
#4 | EPO (European Patent Office) | 5 | |
#5 | United States | 5 | |
#6 | China | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Kelly Graham | 30 |
#2 | Porter Kate | 5 |
#3 | Laczka Olivier | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021007618A1 | Immuno-oncology therapy using isoflavone compounds | |
EP3445347A1 | Chemotherapy improvements | |
EP3439643A1 | Targeted drug delivery | |
AU2017247008A1 | Isoflavonoid composition with improved pharmacokinetics | |
AU2017247006A1 | Radiotherapy improvements | |
AU2016401508A1 | Improvements in cancer treatment |